🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Baroness Nicola Blackwood, Chair of Genomics England and member of OHC's Advisory Council, is at the forefront of rare disease innovation—bridging science, policy, and patient advocacy. Learn more: lnkd.in/g5NR_5hY

The momentum from Rare Disease Day continues! Read the recap of last month's OHC activities, such as launching our official video and sharing insights in RARE Revolution Magazine, Citeline and Scrip, Citeline Commercial, and the Strategy& Insider Podcast. Read more: tinyurl.com/5n7s85fn

Today, the OHC is at the Rare Disease Research UK 2nd Annual Conference in Manchester. Looking forward to an insightful conference, including a panel on industry partnerships and regulatory frameworks that accelerate innovation for rare disease research and treatments. #RDRUKConf #RDRUK

Yesterday, we were at the MitOX 2025 annual conference organised by Karl Morten at Nuffield Dept of Women's & Reproductive Health. It featured an excellent programme of talks and posters on mitochondrial research: cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.

Scholar Spotlight: Meet Professor Louis Chesler, a 2024 Oxford-Harrington Rare Disease Scholar, working to transform treatment for rare brain cancers using innovative, switchable CAR-T cell therapies. Read more: lnkd.in/dfyEHWPQ

We’re pleased to welcome Majid Jafar, global business leader, philanthropist, and co-founder of the Loulou Foundation, to the Advisory Council of the Oxford-Harrington Rare Disease Centre. Read more: tinyurl.com/2emjxp48

The ADDF and Harrington Discovery Institute are pleased to announce a joint RFP for the 2026 ADDF-Harrington Scholar Award, aimed at accelerating the translation of innovative research that may treat, prevent, slow, or reverse Alzheimer's or related dementias. bit.ly/2rEQkiv

The 3rd of May is #WorldAlstromSyndromeDay! To learn more about this ultra-rare genetic condition, read our Q&A with Kerry Leeson-Beevers, CEO of Alström Syndrome UK. Read more: lnkd.in/dFjTNJ3n #AlstromSyndrome

Dr Bowen Li, Assistant Professor at the University of Toronto and 2024 Oxford-Harrington Rare Disease Scholar, is developing RNA-based therapies for #CysticFibrosis. Harrington Discovery Institute Read more: shorturl.at/3MOZS

This Saturday was #FAAwarenessDay — a powerful reminder of the urgent need for progress in #FriedreichsAtaxia research. Oxford researchers can now apply for the FA Alliance Innovation Fund until 18 June, 2025. 🔗 lnkd.in/dCDa4eP3 #CureFA